AR040720A1 - DIARIL-INDOLONA POLYMORPHES, GALR3 ANTAGONISTS - Google Patents

DIARIL-INDOLONA POLYMORPHES, GALR3 ANTAGONISTS

Info

Publication number
AR040720A1
AR040720A1 AR20030102714A ARP030102714A AR040720A1 AR 040720 A1 AR040720 A1 AR 040720A1 AR 20030102714 A AR20030102714 A AR 20030102714A AR P030102714 A ARP030102714 A AR P030102714A AR 040720 A1 AR040720 A1 AR 040720A1
Authority
AR
Argentina
Prior art keywords
indolona
diaril
polymorphes
galr3
antagonists
Prior art date
Application number
AR20030102714A
Other languages
Spanish (es)
Original Assignee
Synaptic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synaptic Pharma Corp filed Critical Synaptic Pharma Corp
Publication of AR040720A1 publication Critical patent/AR040720A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Formas cristalinas, como así también una forma amorfa de compuesto (1), (1-fenil-3-[[3-(trifluormetil)fenil]imino]-1H-indol-2-ona), con el proceso para su preparación, composiciones que contienen los mismos y con el uso terapéutico de tales composiciones. etiles para tratar depresión y/o ansiedad.Crystalline forms, as well as an amorphous form of compound (1), (1-phenyl-3 - [[3- (trifluoromethyl) phenyl] imino] -1H-indole-2-one), with the process for its preparation, compositions containing the same and with the therapeutic use of such compositions. ethyl to treat depression and / or anxiety.

AR20030102714A 2002-08-07 2003-07-29 DIARIL-INDOLONA POLYMORPHES, GALR3 ANTAGONISTS AR040720A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21538102A 2002-08-07 2002-08-07

Publications (1)

Publication Number Publication Date
AR040720A1 true AR040720A1 (en) 2005-04-20

Family

ID=31714273

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102714A AR040720A1 (en) 2002-08-07 2003-07-29 DIARIL-INDOLONA POLYMORPHES, GALR3 ANTAGONISTS

Country Status (6)

Country Link
AR (1) AR040720A1 (en)
AU (1) AU2003282412A1 (en)
PE (1) PE20040756A1 (en)
TW (1) TW200404779A (en)
UY (1) UY27925A1 (en)
WO (1) WO2004014855A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277842B1 (en) 2012-01-20 2012-10-02 Dart Neuroscience (Cayman) Ltd. Enteric-coated HT-2157 compositions and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441570A (en) * 1966-01-20 1969-04-29 Parke Davis & Co 3-tertiary aminoalkylamino-3-phenyl oxindole compounds
US3778470A (en) * 1972-08-23 1973-12-11 A Sallman Chemical intermediates for the production of substituted 2-anilinophenylacetic acids and esters
FR2673532B1 (en) * 1991-03-05 1993-06-11 Oreal PROCESS FOR DYEING KERATINIC FIBERS ASSOCIATING ISATINE OR DERIVATIVES THEREOF WITH AMINOPYRIDINE OR AMINOPYRIMIDINE, AND DYEING AGENTS.

Also Published As

Publication number Publication date
UY27925A1 (en) 2004-03-31
WO2004014855A1 (en) 2004-02-19
AU2003282412A1 (en) 2004-02-25
PE20040756A1 (en) 2004-11-06
TW200404779A (en) 2004-04-01

Similar Documents

Publication Publication Date Title
UY28150A1 (en) THERAPEUTIC AGENTS
BRPI0516187A (en) process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
ECSP045345A (en) TREATMENT OF GASTROPARESIA
AR068369A1 (en) N4 XINAFOATE SALT - [(2,2-DIFLUOR-4H-BENZO [1,4] OXAZIN-3-ON) -6-IL] -5-FLUOR-N2- [3- (METHYLAMINOCARBONYLMETHYLENE) -FENYL] 2 , 4-PYRIMIDINDIAMINE "
UY27740A1 (en) NEW COMPOUNDS
CR9723A (en) NEW CRYSTAL FORM OF A PIRIDAZINO DERIVATIVE [4,5-B] INDOL
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
BRPI0411528A (en) use of isomalt as prebiotic
ES2422556T3 (en) Viral hepatitis treatment
CL2010001348A1 (en) Compounds derived from 1-oxo-2,3-dihydro-1h-isoindolin-5-yl) -isoxazol-3-carboxamide, enhancers of mglur2; pharmaceutical composition; and its use to relieve symptoms or reduce the appearance of symptoms of ezchizophrenia or anxiety.
UY30314A1 (en) BENZONITRILE DERIVATIVES REPLACED WITH GLUCOPYRANOSIL, PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS OF THIS TYPE, USE AND PROCEDURE FOR MANUFACTURING
UY27894A1 (en) CINAMIDE DERIVATIVES
BRPI0417717A (en) compound, pharmaceutical composition, and use of a compound
CR8086A (en) COMPOUNDS OF 1,2,4-OXADIAZOL BENZOIC ACID AND ITS USE FOR SUPPRESSION OF MUTATIONS WITHOUT SENSE
UY29459A1 (en) ASTORAPINE MALEATE ORTHROCHEMICAL CRYSTAL FORM AND ITS USE IN THE TREATMENT OF MENTAL DISORDERS
ECSP099706A (en) NEW DERIVATIVES OF N- (8-HETEROARILTETRAHIDRONAFTALEN-2YL) AND N- (5-HETEROARILCROMAN-3-IL) CARBOXAMIDE FOR THE TREATMENT OF PAIN
CR7583A (en) NEW VENLAFAXINA O-DESMETIL FORMAMATE SALT
GT200300015A (en) AZA-ARILPIPERAZINAS
SV2007002526A (en) DIARILSULFONA SULFONAMIDS AND THE USE OF THE SAME REF. P1018
UY28737A1 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS
BRPI0513944A (en) substantially pure form of a quinazoline compound, use of a quinazoline compound and composition
BRPI0408353A (en) compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound
ATE413173T1 (en) PHENYLPIPERAZINE DERIVATIVES WITH A COMBINATION OF PARTIAL DOPAMINE D2 RECEPTOR AGONISM AND SEROTONIN REUPPOST INHIBITION
ECSP12007431A (en) ORGANIC COMPOUNDS
PA8575601A1 (en) PROCEDURE FOR PREPARATION, MEDICATIONS THAT INCLUDE THESE COMPOUNDS AND THEIR USE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal